Innate Immunity Unit, Institut Pasteur, Université Paris Cité, Inserm U1223, Paris, France.
Immunol Rev. 2024 May;323(1):126-137. doi: 10.1111/imr.13322. Epub 2024 Mar 16.
Group 3 innate lymphoid cells (ILC3s) are tissue-resident immune lymphocytes that critically regulate intestinal homeostasis, organogenesis, and immunity. ILC3s possess the capacity to "sense" the inflammatory environment within tissues, especially in the context of pathogen challenges that imprints durable non-antigen-specific changes in ILC3 function. As such, ILC3s become a new actor in the emerging field of trained innate immunity. Here, we summarize recent discoveries regarding ILC3 responses to bacterial challenges and the role these encounters play in triggering trained innate immunity. We further discuss how signaling events throughout ILC3 ontogeny potentially control the development and function of trained ILC3s. Finally, we highlight the open questions surrounding ILC3 "training" the answers to which may reveal new insights into innate immunity. Understanding the fundamental concepts behind trained innate immunity could potentially lead to the development of new strategies for improving immunity-based modulation therapies for inflammation, infectious diseases, and cancer.
第三组固有淋巴细胞(ILC3)是组织驻留的免疫淋巴细胞,对肠道稳态、器官发生和免疫具有重要的调节作用。ILC3 具有“感知”组织内炎症环境的能力,特别是在病原体挑战的情况下,这种能力会在 ILC3 功能上产生持久的非抗原特异性变化。因此,ILC3 成为新兴的训练性先天免疫领域的一个新角色。在这里,我们总结了最近关于 ILC3 对细菌挑战的反应以及这些接触在触发训练性先天免疫中的作用的发现。我们进一步讨论了 ILC3 发育过程中的信号事件如何控制训练性 ILC3 的发育和功能。最后,我们强调了围绕 ILC3“训练”的问题,这些问题的答案可能揭示出对先天免疫的新见解。理解训练性先天免疫的基本概念可能为改善炎症、传染病和癌症的基于免疫的调节治疗策略的发展提供新的思路。